These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. Bullingham R; Monroe S; Nicholls A; Hale M J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345 [TBL] [Abstract][Full Text] [Related]
30. N-Acetyl, 4-O-methyldopa, a major metabolite of L-4-O-methyldopa in man and rat. Mathieu P; Greffe J; Deruaz D; Guilluy R; Gjessing L Biochem Pharmacol; 1976 Mar; 25(5):497-500. PubMed ID: 942485 [No Abstract] [Full Text] [Related]
31. Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo. Chikhale PJ; Borchardt RT Drug Metab Dispos; 1994; 22(4):592-600. PubMed ID: 7956735 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers. Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites. Zavisca FG; Breau AP; Wurtman RJ Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531 [TBL] [Abstract][Full Text] [Related]
34. Metabolic disposition and cardiovascular effects of methyldopate in unanesthetized rhesus monkeys. Walson PD; Marshall KS; Forsyth RP; Rapoport R; Melmon KL; Castagnoli N J Pharmacol Exp Ther; 1975 Oct; 195(1):151-8. PubMed ID: 810574 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236 [TBL] [Abstract][Full Text] [Related]
37. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing. Straehl P; Galeazzi RL; Soliva M Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure. Rönn O Acta Med Scand Suppl; 1982; 659():89-98. PubMed ID: 6127901 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability. Gilfrich HJ; Kremer G; Möhrke W; Mutschler E; Völger KD Eur J Clin Pharmacol; 1983; 25(2):237-41. PubMed ID: 6628507 [TBL] [Abstract][Full Text] [Related]
40. Lack of first-pass metabolism of ethanol at blood concentrations in the social drinking range. Wagner JG Life Sci; 1986 Aug; 39(5):407-14. PubMed ID: 3736333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]